Publications
Key publications
Access to medicines and health products programme: annual report 2020 (2021)
The 2020 annual report of the Access to Medicines and Health Products (AMP) programme highlights some of the work done by the Regional Office in collaboration with agencies and partners.
Assessing the magnitude and nature of shortages of essential medicines and vaccines: focus on the WHO European Region (2020)
This report was commissioned to support WHO’s work implementing the Sixty-ninth World Health Assembly resolution WHA69.25 of 2016 on addressing the global shortage of medicines and vaccines.
Current status of health intervention and technology assessment in the Balkan region (2020)
This report provides an overview of the developmental status of health technology assessment (HTA) in the region, including facilitators and barriers.
Health technologies and pharmaceuticals programme annual report 2019
The work of the HTP Programme focuses on health system strengthening, supporting the development, revision and implementation of comprehensive pharmaceutical sector policies. In addition, the Programme has an important convening role, bringing together national and international experts and national colleagues to promote cross-country dialogue and to share country experiences.
Expert meeting on market transparency to improve access to high-priced innovative medicines (2020)
On 18 February 2020, the Health Technologies and Pharmaceuticals Programme within the WHO Division of Health Systems and Public Health convened a high-level informal expert meeting on the situation regarding access to innovative, high-value medicines in Europe.
Cross-country collaborations to improve access to medicines and vaccines in the WHO European Region (2020)
This report assesses five government-led, voluntary cross-country collaborations in the WHO European Region that aim to improve access to essential medicines through joint activities.
Strengthening the Health Systems Response to COVID-19 Technical guidance #4 (1 May 2020)
The purpose of this paper is to support pharmacists and other staff working in community pharmacies with guidance on the issues raised by the COVID-19 outbreak.
WHO Regional Office for Europe advice on the use of experimental medicines for the treatment of COVID-19 patients (09 April 2020)
This advice was developed to address questions from Member States regarding the use of experimental medicines in the treatment of COVID-19 patients.
National priority assistive product list development in low resource countries: lessons learned from Tajikistan (2020)
Disability and Rehabilitation: Assistive Technology, Online journal, April 2020
Assessing non-prescription and inappropriate use of antibiotics (2019)
Respondents reported a wide range of activities in support of appropriate use of antimicrobials that targeted the general public, doctors and pharmacists.
WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network. AMC data 2011–2017(2020)
This report updates analyses of data on antimicrobial medicines consumption collected for the period from 2011 to 2017 from non-European Union countries and areas in the WHO European Region.
The legal and regulatory framework for community pharmacies in the WHO European Region (2019)
This report provides an overview of the main possible components and provisions of the legal and regulatory framework for community pharmacies and their activities in Europe.
Medicines Reimbursement Policies in Europe (2018)
This report reviews and analyses different reimbursement policies for medicines applied by countries in the WHO European region.
Evaluation of the Affordable Medicines Programme in Ukraine (2019)
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases.
Evidence brief for policy. Antibiotic prescribing in long-term care facilities for the elderly (2018)
The Ministry of Health of Slovenia commissioned this evidence brief for policy, to be published under the aegis of the WHO European Evidence-informed Policy Network, to develop evidence-informed options for the country to consider in tackling the problem of prescribing broad-spectrum antibiotics to elderly people in long-term care facilities.
Antimicrobial Medicines Consumption (AMC) Network. AMC data 2011–2014 (2017)
This report sets out and analyses data on antimicrobial medicines consumption collected from non-European Union countries in the WHO European Region and Kosovo (in accordance with Security Council resolution 1244 (1999)).
Challenges and opportunities in improving access to medicines through efficient public procurement in the WHO European Region (2016)
This report reviews how different public procurement practices can influence prices and ensure supply security for pharmaceuticals.
Pharmaceutical pricing and reimbursement reform in Kyrgyzstan (2016)
This report explores the causes of high out-of-pocket (OOP) payments for outpatient medicines in Kyrgyzstan and develops policy recommendations to reduce them.
Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research
This report, with a focus on sustainable access to new medicines, reviews policies that affect medicines throughout their lifecycle (from research and development to disinvestment), examining the current evidence base across Europe.
Availability of medicines in Estonia: an analysis of existing barriers and options to address them (2016)
This study aims to identify possible barriers to increasing the availability of medicines in Estonia and to suggest options to overcome them.
